1,779
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

Non-invasive cardiac mapping for non-response in cardiac resynchronization therapy

ORCID Icon, , &
Pages 109-117 | Received 04 Mar 2019, Accepted 29 Apr 2019, Published online: 23 May 2019

References

  • Vernooy K, van Deursen CJ, Strik M, et al. Strategies to improve cardiac resynchronization therapy. Nat Rev Cardiol. 2014;11:481–493.
  • Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in Collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281–2329.
  • Derval N, Duchateau J, Mahida S, et al. Distinctive left ventricular activations associated with ECG pattern in heart failure patients. Circ Arrhythm Electrophysiol. 2017;10:6.
  • Strik M, van Deursen CJ, van Middendorp LB, et al. Transseptal conduction as an important determinant for cardiac resynchronization therapy, as revealed by extensive electrical mapping in the dyssynchronous canine heart. Circ Arrhythm Electrophysiol. 2013;6:682–689.
  • Strik M, van Middendorp LB, Houthuizen P, et al. Interplay of electrical wavefronts as determinant of the response to cardiac resynchronization therapy in dyssynchronous canine hearts. Circ Arrhythm Electrophysiol. 2013;6:924–931.
  • Strik M, Ploux S, Huntjens PR, et al. Response to cardiac resynchronization therapy is determined by intrinsic electrical substrate rather than by its modification. Int J Cardiol. 2018;270:143–148.
  • Ploux S, Lumens J, Whinnett Z, et al. Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. J Am Coll Cardiol. 2013;61:2435–2443.
  • Lumens J, Ploux S, Strik M, et al. Comparative electromechanical and hemodynamic effects of left ventricular and biventricular pacing in dyssynchronous heart failure: electrical resynchronization versus left-right ventricular interaction. J Am Coll Cardiol. 2013;62:2395–2403.
  • Huntjens PR, Ploux S, Strik M, et al. Electrical substrates driving response to cardiac resynchronization therapy: a combined clinical-computational evaluation. Circ Arrhythm Electrophysiol. 2018;11:e005647.
  • Bank AJ, Gage RM, Curtin AE, et al. Body surface activation mapping of electrical dyssynchrony in cardiac resynchronization therapy patients: Potential for optimization. J Electrocardiol. 2018;51:534–541.
  • Johnson WB, Vatterott PJ, Peterson MA, et al. Body surface mapping using an ECG belt to characterize electrical heterogeneity for different left ventricular pacing sites during cardiac resynchronization: Relationship with acute hemodynamic improvement. Heart Rhythm. 2017;14:385–391.
  • Gage RM, Curtin AE, Burns KV, et al. Changes in electrical dyssynchrony by body surface mapping predict left ventricular remodeling in patients with cardiac resynchronization therapy. Heart Rhythm. 2017;14:392–399.
  • Jia P, Ramanathan C, Ghanem RN, et al. Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responses. Heart Rhythm. 2006;3:296–310.
  • Eschalier R, Ploux S, Lumens J, et al. Detailed analysis of ventricular activation sequences during right ventricular apical pacing and left bundle branch block and the potential implications for cardiac resynchronization therapy. Heart Rhythm. 2015;12:137–143.
  • Providencia R, Marijon E, Barra S, et al. Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapy. Int J Cardiol. 2018;260:82–87.
  • Strik M, Ploux S, Vernooy K, et al. Cardiac resynchronization therapy: refocus on the electrical substrate. Circ J. 2011;75:1297–1304.
  • Rademakers LM, van Kerckhoven R, van Deursen CJ, et al. Myocardial infarction does not preclude electrical and hemodynamic benefits of cardiac resynchronization therapy in dyssynchronous canine hearts. Circ Arrhythm Electrophysiol. 2010;3:361.
  • Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59:1509–1518.
  • Nguyen UC, Cluitmans MJM, Strik M, et al. Integration of cardiac magnetic resonance imaging, electrocardiographic imaging, and coronary venous computed tomography angiography for guidance of left ventricular lead positioning. Europace. 2019;21:626–635.
  • Engels EB, Mafi-Rad M, van Stipdonk AM, et al. Why QRS duration should be replaced by better measures of electrical activation to improve patient selection for cardiac resynchronization therapy. J Cardiovasc Trans Res. 2016;9:257–265.
  • van Stipdonk AMW, Vanbelle S, Ter Horst IAH, et al. Large variability in clinical judgement and definitions of left bundle branch block to identify candidates for cardiac resynchronisation therapy. Int J Cardiol. 2019;286:61–65.
  • Caputo ML, van Stipdonk A, Illner A, et al. The definition of left bundle branch block influences the response to cardiac resynchronization therapy. Int J Cardiol. 2018;269:165–169.
  • Duchateau J, Sacher F, Pambrun T, et al. Performance and limitations of noninvasive cardiac activation mapping. Heart Rhythm. 2018;16:435–442.
  • Ploux S, Eschalier R, Whinnett ZI, et al. Electrical dyssynchrony induced by biventricular pacing: implications for patient selection and therapy improvement. Heart Rhythm. 2015;12:782–791.
  • Mafi Rad M, Blaauw Y, Dinh T, et al. Different regions of latest electrical activation during left bundle-branch block and right ventricular pacing in cardiac resynchronization therapy patients determined by coronary venous electro-anatomic mapping. Eur J Heart Fail. 2014;16:1214–1222.
  • Whinnett ZI, Francis DP, Denis A, et al. Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice. Int J Cardiol. 2013;168:2228–2237.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.